| scholarly article | Q13442814 |
| P50 | author | Ali Sie | Q56376466 |
| Michael Lanzer | Q80359367 | ||
| P2093 | author name string | Boubacar Coulibaly | |
| Cecilia Sanchez | |||
| Thomas Jänisch | |||
| Carolin Geiger | |||
| Guillaume Compaore | |||
| Martin Dittmer | |||
| P2860 | cites work | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 |
| Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso | Q24803565 | ||
| Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841] | Q24815501 | ||
| Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria | Q27861937 | ||
| Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out | Q28477515 | ||
| Epidemiology of drug-resistant malaria | Q30830669 | ||
| The great failure of malaria control in Africa: a district perspective from Burkina Faso | Q33286751 | ||
| Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial | Q33784329 | ||
| Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data | Q33805770 | ||
| Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique. | Q33817503 | ||
| Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations | Q34134036 | ||
| Malaria in a holoendemic area of Burkina Faso: a cross-sectional study | Q34485136 | ||
| Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. | Q34944810 | ||
| Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum | Q35220888 | ||
| Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy | Q36051104 | ||
| Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya | Q36077922 | ||
| Drug resistant Plasmodium falciparum in an area of seasonal transmission | Q36109401 | ||
| Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas | Q36316144 | ||
| Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in North-Western Burkina Faso between 2000 and 2009-2012 | Q36803604 | ||
| Access to malaria treatment in young children of rural Burkina Faso | Q37465763 | ||
| Intermittent preventive treatment against malaria: an update | Q37747411 | ||
| Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan | Q38855059 | ||
| Substandard anti-malarial drugs in Burkina Faso | Q39124758 | ||
| Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000. | Q41916761 | ||
| Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization | Q41928982 | ||
| Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola | Q41937703 | ||
| Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum | Q41945406 | ||
| Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? | Q43699456 | ||
| Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria | Q43864384 | ||
| High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction | Q48018672 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkina Faso | Q965 |
| malaria | Q12156 | ||
| sulfadoxine | Q411557 | ||
| pyrimethamine | Q421072 | ||
| PPPK-DHPS | Q18970312 | ||
| P304 | page(s) | 690-697 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso | |
| P478 | volume | 19 |
| Q39413965 | Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso. |
| Q33617916 | Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso |
| Q28125934 | Increased Prevalence of Mutant Allele Pfdhps 437G and Pfdhfr Triple Mutation in Plasmodium falciparum Isolates from a Rural Area of Gabon, Three Years after the Change of Malaria Treatment Policy |
| Q53701891 | Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. |
| Q28553597 | Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa |
| Q28125923 | Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine |
| Q37602300 | Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso |
Search more.